Picture EBD Group World of Partnering Opportunities 650x100px
All >

News > Eastern Europe

Please find below news about Belarus, Bulgaria, Czech Republic, Hungary, Moldova, Poland, Romania, Russia, Slovakia and Ukraine as well as about organisations from these countries.

Total search results: 104 | Ordered by Date (descending)
1 2  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Poltreg S.A.. (3/11/24). "Press Release: Poltreg’s State-of-the-Art Manufacturing Facility Has Received Approval to Produce Cellular Therapies from the Chief Pharmaceutical Inspectorate in Poland". 2024-03-11, z.s.. (3/11/24). "Press Release: This Fall Prague Will Be the Stage for a Showcase of Cutting-edge Biotechnologies Featuring Prominent Figures such as Christian A. Stein, Petr Jansa, and other Leading Experts". Prague. 2024-03-11
Poltreg S.A.. (2/21/24). "Press Release: Poltreg Appoints Dan Shelly, PhD, MBA as Chief Business Development Officer to Help It Build Partnerships across Industry and Deliver Milestones". 2024-02-21
Cresset Biomolecular Discovery Ltd.. (2/21/24). "Press Release: Cresset Announces Global Collaboration with Enamine on New Virtual Screening Drug Discovery Technology". Cambridge. 2024-02-21, z.s.. (2/1/24). "Press Release: Petra Kinzlova Became the New Director of the Cluster". Prague. 2024-02-01
Formycon AG. (1/29/24). "Press Release: Gedeon Richter Becomes Strategic Investor of Formycon via Equity Investment". Munich & Budapest. 2024-01-29
Enamine Ltd.. (1/11/24). "Press Release: Enamine and SyntheticGestalt to Collaborate on the Creation of AI-based Model to Facilitate Drug Discovery". Tokyo & Kyiv. 2024-01-11
Affimed N.V.. (1/3/24). "Press Release: Affimed Announces Sale of Wholly-Owned Subsidiary AbCheck". Mannheim. 2024-01-03
Proteros Biostructures GmbH. (9/6/23). "Press Release: Proteros Biostructures and Orion Pharma Agree on a Long-term Multi-target Collaboration". Martinsried. 2023-09-06
Molecure S.A.. (7/21/23). "Press Release: Molecure Completes Successful Secondary Public Offering (SPO) of approximately PLN 50 Million (USD 12 Million)". Warsaw. 2023-07-21
Bioinformatics and Biotechnology Association Moldova. (7/18/23). "Press Release: Bioinformatics and Biotechnology Association Launched in the Republic of Moldova". Chisinau. 2023-07-18
Enamine Ltd.. (5/22/23). "Press Release: Enamine Launches a New Chemistry Site in Germany". Kyiv. 2023-05-22
Qiagen N.V.. (5/15/23). "Press Release: Qiagen Expands Enzyme Offering to Support Individual Life Science Research Labs Worldwide". Berlin. 2023-05-15
Molecure S.A.. (3/30/23). "Press Release: Molecure Announces Full Year Financial 2022 Results – a Year of Significant Progress". Warsaw. 2023-03-30
i&i Biotech Fund. (3/15/23). "Press Release: i&i Biotech Fund Will Invest up to EUR 340 000 into Czech Startup Sophomer s.r.o.". Prague. 2023-03-15
i&i Prague. (2/7/23). "Press Release: New Startup in Our Portfolio. Sophomer’s Technology Will Make Immunoassays Faster, Easier and Cheaper". Prague. 2023-02-07
Ryvu Therapeutics S.A.. (12/22/22). "Press Release: Ryvu Therapeutics Announces Closing of Equity Offering with Gross Proceeds over PLN 250 Million". Krakow. 2022-12-22
Ryvu Therapeutics S.A.. (12/8/22). "Press Release: Ryvu Therapeutics Initiates Public Offering of Shares [not for US, AU, CA, et al.]". Krakow. 2022-12-08
BioNTech SE. (11/30/22). "Press Release: BioNTech and Ryvu Therapeutics Enter into Global Collaboration to Develop and Commercialize Immuno-Modulatory Small Molecule Candidates". Mainz & Krakow. 2022-11-30
i&i Biotech Fund. (11/30/22). "Press Release: Experienced Businessmen Join Forces with Excellent Science, Invest € 2 Million in the Fund at the IOCB". Prague. 2022-11-30
Sotio Biotech a.s.. (11/29/22). "Press Release: Sotio Exercises Option for Novel Antibody-Drug Conjugate Program under Agreement with LegoChem Biosciences". Prague. 2022-11-29
Selvita S.A.. (11/9/22). "Press Release: Selvita Group Reports Strong Business Performance for Q3 YTD 2022". Kraków. 2022-11-09
Ryvu Therapeutics S.A.. (8/17/22). "Press Release: EIB to Support Ryvu Therapeutics’ Discovery, Research and Development of New Cancer Treatments with €22 Million". 2022-08-17
Bio-Rad Laboratories, Inc.. (8/3/22). "Press Release: Bio-Rad Acquires Curiosity Diagnostics". Hercules, CA. 2022-08-03
Ryvu Therapeutics S.A.. (7/26/22). "Press Release: Ryvu Therapeutics Announces Promotion of Hendrik Nogai and Vatnak Vat-Ho to the Management Board". Kraków. 2022-07-26
intoDNA S.A.. (7/19/22). "Press Release: intoDNA Joins the BioInMed Initiative Gathering Key Medical Biotechnology Companies in Poland". Kraków. 2022-07-19
Ryvu Therapeutics S.A.. (7/7/22). "Press Release: Exelixis and Ryvu Therapeutics Establish Exclusive License Agreement to Develop Novel STING Agonist-Based Targeted Cancer Therapies". Alameda, CA & Krakow. 2022-07-07
Qiagen N.V.. (5/11/22). "Press Release: Qiagen Acquires Majority Stake in Enzymes Provider BLIRT S.A.". Hilden & Germantown, MD. 2022-05-11
Ardigen S.A.. (3/24/22). "Press Release: Lukasz Dutkiewicz, PhD Has Joined Ardigen as a Business Development Director". 2022-03-24
Ryvu Therapeutics S.A.. (3/15/22). "Press Release: Ryvu Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update". Krakow. 2022-03-15
Enamine Ltd.. (3/7/22). "Press Release: Open Letter from Enamine Founder and CEO Dr. Andrey Tolmachov". 2022-03-07
Ryvu Therapeutics S.A.. (12/14/21). "Press Release: Ryvu Announces Option to License Inflammation Program Exercised by Galapagos NV". Tübingen, Houston, TX & New York, NY. 2021-12-14
Sotio Biotech a.s.. (12/2/21). "Press Release: Sotio Secures €280m of Funding to Expand and Advance Clinical Pipeline". Prague, Basel & Cambridge, MA. 2021-12-02
Sotio Biotech a.s.. (11/16/21). "Press Release: Sotio Expands Its Antibody-Drug Conjugate Pipeline with Exclusive Collaboration and License Agreement with LegoChem Biosciences". Prague. 2021-11-16
Selvita S.A.. (7/19/21). "Press Release: Selvita Appoints Dean Bornilla as Vice President of Sales, Head of North America". Krakow. 2021-07-19
Cellink AB. (6/23/21). "Press Release: Cellink’s EpiDerm Skin Model Has Been Approved by the OECD as a Stand-alone in-vitro Test Method for Phototoxicity". 2021-06-23
Moderna, Inc.. (5/19/21). "Press Release: Moderna to Establish an International Business Services Hub in Warsaw, Poland. Entity Complements Six Commercial Entities in Europe". Cambridge, MA. 2021-05-19
Ryvu Therapeutics S.A.. (4/26/21). "Press Release: Ryvu Therapeutics Appoints Vatnak Vat-Ho as Chief Business Officer". Krakow. 2021-04-26
Reig Jofre. (4/20/21). "Press Release: Reig Jofre Consolidates Its International Growth Strategy by Creating in Poland the Subsidiary Reig Jofre Sp. z o.o.". Barcelona. 2021-04-20
Twist Bioscience Corporation. (4/14/21). "Press Release: Pure Biologics Selects Twist Bioscience to Expand Phage Display Technology Capabilities". South San Francisco, CA. 2021-04-14
Ryvu Therapeutics S.A.. (3/16/21). "Press Release: Ryvu Therapeutics Reports Financial Results for 2020". Kraków. 2021-03-16
Enamine Ltd.. (2/24/21). "Press Release: Enamine Extend Collaboration with Prominent Swiss Biotech". Kyiv. 2021-02-24
Turbine Kft.. (1/7/21). "Press Release: Turbine Raises EUR 5.7M to Advance Simulation-first Oncology Pipeline". London & Budapest. 2021-01-07
Galapagos N.V.. (11/5/20). "Press Release: OncoArendi and Galapagos Enter into Exclusive Collaboration on Chitinase Inhibitors in Fibrosis". Mechelen & Warsaw. 2020-11-05
Scope Fluidics S.A.. (10/28/20). "Press Release: Prof. Carl Wittwer – the Legendary Creator of the PCR Technology – Joins the Scope Fluidics Advisory Committee". Warsaw. 2020-10-28
Scope Fluidics S.A.. (9/7/20). "Press Release: Poland – EIB Lends up to EUR 10 Million to Scope Fluidics to Develop Diagnostics Dquipment for Infectious Diseases". Luxembourg & Warsaw. 2020-09-07
Galapagos N.V.. (4/16/20). "Press Release: Galapagos and Ryvu Announce Research Collaboration". Mechelen & Krakow. 2020-04-16
o2h Ventures. (2/15/20). "Press Release: o2h Ventures Makes an Investment in Turbine". Cambridge. 2020-02-15
Scope Fluidics S.A.. (1/16/20). "Press Release: Scope Fluidics Ready for BacterOMIC System Industrialisation". Warsaw. 2020-01-16
KCR S.A.. (12/18/19). "Press Release: KCR Adopts Veeva Vault Clinical Suite". Boston, MA. 2019-12-18
Scope Fluidics S.A.. (12/6/19). "Press Release: Scope Fluidics Has Launched a Manufacturing Line for PCR System Chips". Warsaw. 2019-12-06
AB Sciex (d/b/a Sciex). (9/5/19). "Press Release: Sciex Launches Partner Portal to Support Customer Needs Worldwide and Extend Network". Framingham, MA. 2019-09-05
Novartis AG. (9/3/19). "Press Release: Sandoz Announces Global Deal to Commercialize Proposed Biosimilar Natalizumab, a Key Multiple Sclerosis Medicine". Holzkirchen. 2019-09-03
Unibio International plc. (8/28/19). "Press Release: Unibio Completes USD 15 M (GBP 12.4 M) Financing Round". London & Copenhagen. 2019-08-28
Inveox GmbH. (8/5/19). "Press Release: 17 Million for Future Cancer Diagnoses. Inveox Acquires Further Investment". Munich. 2019-08-05
Atomwise, Inc.. (6/24/19). "Press Release: Atomwise and Enamine to Advance Pediatric Oncology with the World’s First and Largest Ten Billion Compound Virtual Screen". San Francisco, CA & Kiev. 2019-06-24
Thermo Fisher Scientific Inc.. (6/6/19). "Press Release: Thermo Fisher Scientific Acquires HighChem, Provider of Mass Spectrometry Software". San José, CA. 2019-06-06
Selvita S.A.. (5/22/19). "Press Release: Selvita Reports First Quarter 2019 Financial Results and Provides Corporate Update". Krakow. 2019-05-22
Inveox GmbH. (4/2/19). "Press Release: Innovation Across Borders. Inveox Expands to Poland". Garching & Kraków. 2019-04-02
Selvita S.A.. (3/28/19). "Press Release: Selvita to Separate Oncology Therapeutics and Contract Research Business Units into Two Global Companies". Krakow. 2019-03-28
Selvita S.A.. (3/28/19). "Press Release: Selvita Posts 67 Percent Increase in Operating Profit for Services Division, Innovative Research Division Reaches Inflection Point as SEL120 Enters Clinical Development". Krakow. 2019-03-28
Enamine Ltd.. (3/26/19). "Press Release: Enamine Extends Multi-year Drug Discovery Collaboration with Lundbeck". Kiev. 2019-03-26
InflaRx N.V.. (2/6/19). "Press Release: InflaRx Announces Presentation of New Clinical Data with Lead Candidate IFX-1 in Hidradenitis Suppurativa". Jena. 2019-02-06
GamaMabs Pharma S.A.. (9/17/18). "Press Release: GamaMabs Pharma Starts a Phase 2 Study of Monoclonal Antibody GM102 in Patients with Advanced or Metastatic Colorectal Cancer". Paris & Toulouse. 2018-09-17
Optibrium Ltd.. (9/4/18). "Press Release: Optibrium and Enamine Collaboration Extends Commercial Compound Database Access for StarDrop Users". Cambridge & Kiev. 2018-09-04
DataApex. (7/27/18). "Press Release: Clarity Chromatography Software Version 8.0 with Major Changes". Prague. 2018-07-27
Microsaic Systems plc. (6/21/18). "Press Release: Distribution Agreement with Amedis, spol. s ro.". 2018-06-21
Enamine Ltd.. (6/19/18). "Press Release: Enamine and TBD Biodiscovery Collaborate to Provide GMP-based Services". Kiev & Tartu. 2018-06-19
DataApex. (5/30/18). "Press Release: New Partnership. Apix Analytics Has Started Distributing PixL Lab (Clarity Chromatography Software’s OEM Version)". 2018-05-30
DataApex. (3/15/18). "Press Release: New OEM Cooperation in China. Clarity Chromatography Software Available from Welch Scientific Instruments". 2018-03-15
Rentschler Biopharma SE. (2/28/18). "Press Release: Rentschler Biopharma SE Appoints Federico Pollano as Senior Vice President, Business Development". Laupheim. 2018-02-28
Sotio a.s.. (2/27/18). "Press Release: Radek Špíšek to Become New CEO of Sotio". Prague. 2018-02-27
Qiagen N.V.. (2/23/18). "Press Release: Qiagen Opens Shared Services Center in Taguig City, Manila". Manila. 2018-02-23
Selvita S.A.. (2/16/18). "Press Release: Selvita Announces Successful Completion of $41 M Book Building [ NOT FOR DISTRIBUTION IN THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN ]". Kraków. 2018-02-16
Selvita S.A.. (2/6/18). "Press Release: Selvita Appoints Steffen Heeger, M.D., PhD as Chief Medical Officer". Kraków. 2018-02-06
Oncgnostics GmbH. (1/31/18). "Press Release: Reliable Test for Cervical Cancer Triage Now Available in Slovakia and the Czech Republic". Jena. 2018-01-31
Enamine Ltd.. (1/25/18). "Press Release: Enamine Expands Collaboration with UCSF to Explore Synthetically Feasible Chemical Space Enamine REAL database of synthetic compounds accessible via UCSF’s online ZINC platform". Kiev. 2018-01-25
Eurofins Scientific. (1/18/18). "Press Release: Eurofins Enters the Hungarian Market for Food and Feed testing with the Acquisition of Food Analytica Group". 2018-01-18
Enamine Ltd.. (1/10/18). "Press Release: Enamine Supplies DSI Poised Fragment and Analogue Libraries to Diamond Light Source XChem Facility and SGC Oxford Screening Efforts". Kiev & Oxford. 2018-01-10
ChemAxon Kft.. (12/12/17). "Press Release: ChemAxon and Simmaren Form Strategic Partnership to Accelerate the Development of New Software for the Prediction of Human Drug Metabolism". Budapest & Auckland. 2017-12-12
ChemAxon Kft.. (12/5/17). "Press Release: ChemAxon Software Is Integrated into ChemPass’ Novel Drug Design Platform". Budapest & Boston, MA. 2017-12-05
Selvita S.A.. (11/30/17). "Press Release: Selvita Promotes Edyta Jaworska to the Management Board to Strengthen Development in Integrated Drug Discovery Services". Krakow. 2017-11-30
ChemAxon Kft.. (11/21/17). "Press Release: ChemAxon and Dexstr Team Up to Boost Chemistry in Unstructured Data". Budapest, Toulouse & Boston, MA. 2017-11-21
Servier. (11/3/17). "Press Release: Egis Intensifies Its Acquisition Strategy in 2017". 2017-11-03
Selexis S.A.. (9/15/17). "Press Release: Selvita Demonstrates Strong Revenue Growth in H1 2017". Kraków. 2017-09-15
Selvita S.A.. (8/8/17). "Press Release: Selvita and The Leukemia & Lymphoma Society Announce Partnership to Advance SEL120 into Phase I for AML Patients". Krakow & Rye Brook. 2017-08-08
Bruker Corporation. (8/8/17). "Press Release: Hungarian Ministry of Agriculture Selects Bruker NMR FoodScreener for Authentication and Identification of Hungarian Wines". Budapest. 2017-08-08
Enamine Ltd.. (8/1/17). "Press Release: Axxam Enters into a Research Collaboration with Enamine for the Enhancement of the Axxam Screening Collection". Milan & Kiev. 2017-08-01
TATAA Biocenter AB. (7/13/17). "Press Release: TATAA Biocenter and BTU Develop Two-tailed PCR for microRNA Analysis Offering Superior Sensitivity and Specificity". 2017-07-13
Cellnovo. (6/28/17). "Press Release: Cellnovo Signs Expanded Agreement to Build Second Production Line with Flex". Paris. 2017-06-28
Agilent Technologies Inc.. (6/19/17). "Press Release: Agilent Technologies Unveils New Analytical and Purification Solutions at HPLC 2017". Santa Clara, CA. 2017-06-19
Thermo Fisher Scientific Inc.. (6/19/17). "Press Release: New Single Quadrupole Mass Spectrometer and Specialized Columns Designed to Deliver Reproducible and Robust Separations, Increase Analytical Accuracy". Prague. 2017-06-19
Mundipharma International Ltd.. (6/14/17). "Press Release: New Data Show Truxima (CT-P10) to Have Comparable Efficacy and Tolerability in Advanced Follicular Lymphoma to Reference i.v. Rituximab". Cambridge. 2017-06-14
Bioptická Laborator s.r.o.. (5/10/17). "Press Release: Bioptická Laborator Now Offering Panorama NIPT in Czech Republic via Natera's Constellation Cloud-based Software Platform". Pilsen. 2017-05-10
Stratec Biomedical AG. (5/4/17). "Press Release: Stratec Continues Growth in 2017". Birkenfeld. 2017-05-04
Enamine Ltd.. (4/25/17). "Press Release: Enamine to Collaborate with EMBL for Cancer Drug Discovery Research". Kiev. 2017-04-25
Biotest AG. (4/19/17). "Press Release: Biotest AG Opens Sixth Plasma Collection Centre in Hungary". Dreieich. 2017-04-19
Lead Discovery Center GmbH. (4/11/17). "Press Release: LDC and SOTIO Enter License and Collaboration Agreement for Cancer Metabolism Program". Dortmund & Praque. 2017-04-11
Selvita S.A.. (3/28/17). "Press Release: Selvita and Menarini Group Announce Global License Agreement for Clinical Stage Oncology Drug PIM/FLT3 Inhibitor SEL24". Krakow & Berlin. 2017-03-28
Biodesix, Inc.. (3/20/17). "Press Release: Study Results from Biodesix’s Immunotherapy Test Will Be Presented by Dr. Jeffrey Weber. Proteomic Test Identifies Sensitivity and Resistance to Immunotherapy in Cancer Patients". 2017-03-20
1 2  next pagenext page


Picture EBD Group World of Partnering Opportunities 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Berlin Partner Top News Healthtech Company Mika 650x300px

» top